Loading...

Ipp, Eli

Title(s)Professor-in-Residence, Medicine
Phone3105333681
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Mehranbod C, Genter P, Serpas L, Macias J, Campa D, Bermon D, Ipp E. Automated Reminders Improve Retinal Screening Rates in Low Income, Minority Patients with Diabetes and Correct the African American Disparity. J Med Syst. 2019 Dec 09; 44(1):17. PMID: 31820116.
      View in: PubMed
    2. Wu S, Ell K, Jin H, Vidyanti I, Chou CP, Lee PJ, Gross-Schulman S, Sklaroff LM, Belson D, Nezu AM, Hay J, Wang CJ, Scheib G, Di Capua P, Hawkins C, Liu P, Ramirez M, Wu BW, Richman M, Myers C, Agustines D, Dasher R, Kopelowicz A, Allevato J, Roybal M, Ipp E, Haider U, Graham S, Mahabadi V, Guterman J. Comparative Effectiveness of a Technology-Facilitated Depression Care Management Model in Safety-Net Primary Care Patients With Type 2 Diabetes: 6-Month Outcomes of a Large Clinical Trial. J Med Internet Res. 2018 04 23; 20(4):e147. PMID: 29685872.
      View in: PubMed
    3. Adams E, Genter P, Keefe E, Sandow K, Gray V, Rotter JI, Chen YI, Ipp E. The GLP-1 response to glucose does not mediate beta and alpha cell dysfunction in Hispanics with abnormal glucose metabolism. Diabetes Res Clin Pract. 2018 Jan; 135:185-191. PMID: 29155153.
      View in: PubMed
    4. Ipp E, Genter P, Childress K. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med. 2017 03 02; 376(9):890-1. PMID: 28252263.
      View in: PubMed
    5. Lu Y, Serpas L, Genter P, Anderson B, Campa D, Ipp E. Divergent Perceptions of Barriers to Diabetic Retinopathy Screening Among Patients and Care Providers, Los Angeles, California, 2014-2015. Prev Chronic Dis. 2016 10 06; 13:E140. PMID: 27710765.
      View in: PubMed
    6. Lu Y, Serpas L, Genter P, Mehranbod C, Campa D, Ipp E. Disparities in Diabetic Retinopathy Screening Rates Within Minority Populations: Differences in Reported Screening Rates Among African American and Hispanic Patients. Diabetes Care. 2016 Mar; 39(3):e31-2. PMID: 26721811.
      View in: PubMed
    7. Kuo JZ, Guo X, Klein R, Klein BE, Genter P, Roll K, Hai Y, Goodarzi MO, Rotter JI, Chen YD, Ipp E. Adiponectin, Insulin Sensitivity and Diabetic Retinopathy in Latinos With Type 2 Diabetes. J Clin Endocrinol Metab. 2015 Sep; 100(9):3348-55. PMID: 26020763.
      View in: PubMed
    8. Kuo JZ, Guo X, Klein R, Klein BE, Weinreb RN, Genter P, Hsiao FC, Goodarzi MO, Rotter JI, Chen YD, Ipp E. Association of fasting insulin and C peptide with diabetic retinopathy in Latinos with type 2 diabetes. BMJ Open Diabetes Res Care. 2014; 2(1):e000027. PMID: 25452868.
      View in: PubMed
    9. Chlebowski RT, McTiernan A, Wactawski-Wende J, Manson JE, Aragaki AK, Rohan T, Ipp E, Kaklamani VG, Vitolins M, Wallace R, Gunter M, Phillips LS, Strickler H, Margolis K, Euhus DM. Diabetes, metformin, and breast cancer in postmenopausal women. J Clin Oncol. 2012 Aug 10; 30(23):2844-52. PMID: 22689798.
      View in: PubMed
    10. Patterson ME, Mao CS, Yeh MW, Ipp E, Cortina G, Barank D, Vasinrapee P, Pawlikowska-Haddal A, Lee WN, Yee JK. Hyperinsulinism presenting in childhood and treatment by conservative pancreatectomy. Endocr Pract. 2012 May-Jun; 18(3):e52-6. PMID: 22548943.
      View in: PubMed
    11. Djekic K, Mouzeyan A, Ipp E. Latent autoimmune diabetes of adults is phenotypically similar to type 1 diabetes in a minority population. J Clin Endocrinol Metab. 2012 Mar; 97(3):E409-13. PMID: 22205710.
      View in: PubMed
    12. Adler S, Pahl M, Abboud H, Nicholas S, Ipp E, Seldin M. Mexican-American admixture mapping analyses for diabetic nephropathy in type 2 diabetes mellitus. Semin Nephrol. 2010 Mar; 30(2):141-9. PMID: 20347643.
      View in: PubMed
    13. Charfen MA, Ipp E, Kaji AH, Saleh T, Qazi MF, Lewis RJ. Detection of undiagnosed diabetes and prediabetic states in high-risk emergency department patients. Acad Emerg Med. 2009 May; 16(5):394-402. PMID: 19302369.
      View in: PubMed
    14. Pettitt DJ, Okada Wollitzer A, Jovanovic L, He G, Ipp E. Decreasing the risk of diabetic retinopathy in a study of case management: the California Medi-Cal Type 2 Diabetes Study. Diabetes Care. 2005 Dec; 28(12):2819-22. PMID: 16306539.
      View in: PubMed
    15. Mehrotra R, Budoff M, Hokanson JE, Ipp E, Takasu J, Adler S. Progression of coronary artery calcification in diabetics with and without chronic kidney disease. Kidney Int. 2005 Sep; 68(3):1258-66. PMID: 16105059.
      View in: PubMed
    16. Ipp E, Aquino RL, Christenson P. Point: Self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin: the sanguine approach. Diabetes Care. 2005 Jun; 28(6):1528-30. PMID: 15920087.
      View in: PubMed
    17. Mehrotra R, Westenfeld R, Christenson P, Budoff M, Ipp E, Takasu J, Gupta A, Norris K, Ketteler M, Adler S. Serum fetuin-A in nondialyzed patients with diabetic nephropathy: relationship with coronary artery calcification. Kidney Int. 2005 Mar; 67(3):1070-7. PMID: 15698447.
      View in: PubMed
    18. Mehrotra R, Budoff M, Christenson P, Ipp E, Takasu J, Gupta A, Norris K, Adler S. Determinants of coronary artery calcification in diabetics with and without nephropathy. Kidney Int. 2004 Nov; 66(5):2022-31. PMID: 15496175.
      View in: PubMed
    19. Mao CS, Berman N, Ipp E. Loss of entrainment of high-frequency plasma insulin oscillations in type 2 diabetes is likely a glucose-specific beta-cell defect. Am J Physiol Endocrinol Metab. 2004 Jul; 287(1):E50-4. PMID: 14998786.
      View in: PubMed